DE69509624D1 - Verfahren zur Herstellung von 1-(2'-Deoxy-2',2'-difluoro-D-ribofuranosyl)-4-amino-pyrimidin-2-on-hydrochlorid - Google Patents

Verfahren zur Herstellung von 1-(2'-Deoxy-2',2'-difluoro-D-ribofuranosyl)-4-amino-pyrimidin-2-on-hydrochlorid

Info

Publication number
DE69509624D1
DE69509624D1 DE69509624T DE69509624T DE69509624D1 DE 69509624 D1 DE69509624 D1 DE 69509624D1 DE 69509624 T DE69509624 T DE 69509624T DE 69509624 T DE69509624 T DE 69509624T DE 69509624 D1 DE69509624 D1 DE 69509624D1
Authority
DE
Germany
Prior art keywords
aminopyrimidin
ribofuranosyl
deoxy
difluoro
hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69509624T
Other languages
English (en)
Other versions
DE69509624T2 (de
Inventor
Richard Alan Berglund
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23397211&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69509624(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of DE69509624D1 publication Critical patent/DE69509624D1/de
Publication of DE69509624T2 publication Critical patent/DE69509624T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
DE69509624T 1994-12-13 1995-11-09 Verfahren zur Herstellung von 1-(2'-Deoxy-2',2'-difluoro-D-ribofuranosyl)-4-amino-pyrimidin-2-on-hydrochlorid Expired - Lifetime DE69509624T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/355,372 US5637688A (en) 1994-12-13 1994-12-13 Process for preparing 1-(2'-deoxy-2'-difluoro-d-ribofuranosyl)-4-aminopyrimidin-2-one hydrochloride

Publications (2)

Publication Number Publication Date
DE69509624D1 true DE69509624D1 (de) 1999-06-17
DE69509624T2 DE69509624T2 (de) 1999-10-07

Family

ID=23397211

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69509624T Expired - Lifetime DE69509624T2 (de) 1994-12-13 1995-11-09 Verfahren zur Herstellung von 1-(2'-Deoxy-2',2'-difluoro-D-ribofuranosyl)-4-amino-pyrimidin-2-on-hydrochlorid

Country Status (31)

Country Link
US (2) US5637688A (de)
EP (1) EP0719788B1 (de)
JP (1) JPH10510806A (de)
KR (1) KR100424991B1 (de)
CN (1) CN1047177C (de)
AR (1) AR001041A1 (de)
AT (1) ATE179986T1 (de)
AU (1) AU689674B2 (de)
BG (1) BG62738B1 (de)
BR (1) BR9509979A (de)
CO (1) CO4520286A1 (de)
CZ (1) CZ290941B6 (de)
DE (1) DE69509624T2 (de)
DK (1) DK0719788T3 (de)
ES (1) ES2130542T3 (de)
GR (1) GR3030265T3 (de)
HU (1) HU219021B (de)
IL (1) IL115852A (de)
MY (1) MY112488A (de)
NO (1) NO306783B1 (de)
NZ (1) NZ296476A (de)
PE (1) PE49296A1 (de)
PL (1) PL181732B1 (de)
RO (1) RO117327B1 (de)
RU (1) RU2154648C2 (de)
SI (1) SI0719788T1 (de)
TW (1) TW379226B (de)
UA (1) UA48152C2 (de)
WO (1) WO1996018637A1 (de)
YU (1) YU49314B (de)
ZA (1) ZA959320B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637688A (en) * 1994-12-13 1997-06-10 Eli Lilly And Company Process for preparing 1-(2'-deoxy-2'-difluoro-d-ribofuranosyl)-4-aminopyrimidin-2-one hydrochloride
EP0870506A1 (de) * 1997-04-11 1998-10-14 Eli Lilly And Company Zusammentsetzungen enthaltend ein Cryptophycin Derivat in Kombination mit einem synchronisierten Wirkstoff oder Aktivierungsmittel zur Behandlung von Krebs
CZ298511B6 (cs) * 1997-12-22 2007-10-24 Schering Corporation Použití benzocykloheptapyridinových sloucenin proprípravu farmaceutického prípravku pro použití v kombinaci s antineoplastickým lécivem a/nebo radioterapií k lécení proliferacních onemocnení
US6376470B1 (en) 1999-09-23 2002-04-23 Enzon, Inc. Polymer conjugates of ara-C and ara-C derivatives
AU2001296558A1 (en) 2000-10-03 2002-04-15 Oncopharmaceutical, Inc. Inhibitors of angiogenesis and tumor growth for local and systemic administration
WO2005014010A1 (en) * 2003-07-24 2005-02-17 Eli Lilly And Company Pharmaceutical composition comprising gemcitabine and cyclodextrines
US7214791B2 (en) * 2004-07-01 2007-05-08 Shenzhen Hande Technology Co., Ltd. Method for preparation of 2′-deoxy-2′, 2′-difluoro-β-cytidine or pharmaceutically acceptable salts thereof by using 1,6-anhydro-β-d-glucose as raw material
TW200606159A (en) * 2004-07-30 2006-02-16 Pharmaessentia Corp Stereoselective synthesis of β-nucleosides
WO2006070985A1 (en) * 2004-12-30 2006-07-06 Hanmi Pharm. Co., Ltd. METHOD FOR THE PREPARATION OF 2#-DEOXY-2#,2#-DIFLUOROCYTIDINE
BRPI0520050A2 (pt) * 2005-03-04 2009-11-17 Dabur Pharma Ltd composto, processo para a preparação de um composto e processo de glicosilação estereoseletiva para a preparação de mais de 99% de anÈmero b enriquecido de hidrocloreto de gencitabina
WO2006095359A1 (en) * 2005-03-10 2006-09-14 Sms Pharmaceuticals Limited Synthesis of 2-deoxy-2, 2-di fluoro-d-ribo furanose-3, 5 di(4-methy/4-nitro-chloro)benzoate and its conversion to gemcitabine hydrochloride thereof
TWI368621B (en) * 2005-05-02 2012-07-21 Leyoung Biotech Co Ltd Stereoselective synthesis of β-nucleosides
CN100391966C (zh) * 2005-06-17 2008-06-04 华东师范大学 一种2’-脱氧-2’,2’-二氟-胞苷合成的方法
US8193354B2 (en) 2005-10-28 2012-06-05 Arch Pharmalabs Limited Process for preparation of Gemcitabine hydrochloride
KR101259637B1 (ko) * 2005-12-14 2013-04-30 주식회사종근당 1-(2´-데옥시-2´,2´-디플루오로-디-리보푸라노실)-4-아미노피리미딘-2-온또는 그의 염산염의 제조방법
US20090069354A1 (en) * 2007-09-12 2009-03-12 Protia, Llc Deuterium-enriched gemcitabine
JO2778B1 (en) 2007-10-16 2014-03-15 ايساي انك Certain vehicles, installations and methods
AU2008323923A1 (en) * 2007-11-06 2009-05-14 Pharmaessentia Corporation Novel synthesis of beta-nucleosides
IT1393062B1 (it) * 2008-10-23 2012-04-11 Prime Europ Therapeuticals Procedimento per la preparazione di gemcitabina cloridrato
ES2593088T3 (es) * 2009-04-06 2016-12-05 Otsuka Pharmaceutical Co., Ltd. Derivados de (2'-Desoxi-Ribofuranosil)-1,3,4,7-Tetrahidro-(1,3)Diazepin-2-ona para Tratamiento de Cáncer
EP2416781B1 (de) * 2009-04-06 2017-03-08 Otsuka Pharmaceutical Co., Ltd. Kombination von antineoplastischen arzneimitteln auf cytidin-basis mit cytidin-deaminase-inhibitor und ihre verwendung in der krebstherapie
US8609631B2 (en) 2009-04-06 2013-12-17 Eisai Inc. Compositions and methods for treating cancer
TWI503121B (zh) * 2009-04-06 2015-10-11 Otsuka Pharma Co Ltd 用以治療癌症之組成物及方法
CN101525361B (zh) * 2009-04-21 2010-11-17 济南圣鲁金药物技术开发有限公司 基于吉西他滨结构的前药及其合成方法及应用
JP5801715B2 (ja) * 2009-05-15 2015-10-28 Delta−Fly Pharma株式会社 1−(2’−シアノ−2’−デオキシ−β−D−アラビノフラノシル)シトシン・一塩酸塩の新規安定形結晶
CN101628927B (zh) * 2009-08-07 2012-10-10 卡硼瑞(北京)科技有限公司 以1,3,5-三-O-苯甲酰基-α-D-呋喃核糖为原料立体选择性制备β-二氟胞苷盐酸盐的方法
CN102453064B (zh) * 2011-06-30 2014-07-09 江苏豪森药业股份有限公司 制备吉西他滨盐酸盐的方法
CN102659884B (zh) * 2012-04-23 2014-07-02 南京臣功制药股份有限公司 盐酸吉西他滨的提纯方法
CN103224541B (zh) * 2013-04-27 2015-07-01 江苏豪森药业股份有限公司 吉西他滨α-异构体转化回收工艺
CN104402945A (zh) * 2014-11-27 2015-03-11 苏州乔纳森新材料科技有限公司 一种3-脱氧-1,2-o-异丙叉-d-呋喃木糖的合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3817978A (en) * 1971-06-16 1974-06-18 Syntex Inc 4-fluoro nucleosides and sugar intermediates, and methods of preparing
JPS5924999B2 (ja) * 1978-06-10 1984-06-13 富山化学工業株式会社 新規な5−フルオロ−2′−デオキシ−β−ウリジン誘導体の製造法
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
IL77133A (en) * 1984-12-04 1991-01-31 Lilly Co Eli Antineoplastic pharmaceutical compositions containing pentofuranoside derivatives,some new such compounds and their preparation
US4965374A (en) * 1987-08-28 1990-10-23 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
US5223608A (en) * 1987-08-28 1993-06-29 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
AU4134793A (en) * 1992-06-22 1993-12-23 Eli Lilly And Company 2'-deoxy-2',2'-difluoro(2,6,8-substituted) purine nucleosides having anti-viral and anti-cancer activity and intermediates
EP0577304B1 (de) * 1992-06-22 1997-03-05 Eli Lilly And Company Verfahren zur Stereoselektivanionglycosylierung
UA41261C2 (uk) * 1992-06-22 2001-09-17 Елі Ліллі Енд Компані Спосіб одержання збагачених бета-аномером нуклеозидів
TW356472B (en) * 1992-09-01 1999-04-21 Lilly Co Eli A process for anomerizing nucleosides
US5637688A (en) * 1994-12-13 1997-06-10 Eli Lilly And Company Process for preparing 1-(2'-deoxy-2'-difluoro-d-ribofuranosyl)-4-aminopyrimidin-2-one hydrochloride

Also Published As

Publication number Publication date
US5637688A (en) 1997-06-10
NO306783B1 (no) 1999-12-20
NZ296476A (en) 1998-12-23
BG101591A (en) 1998-03-31
GR3030265T3 (en) 1999-08-31
CN1169728A (zh) 1998-01-07
RU2154648C2 (ru) 2000-08-20
DE69509624T2 (de) 1999-10-07
YU70895A (sh) 1998-09-18
UA48152C2 (uk) 2002-08-15
NO972679D0 (no) 1997-06-11
IL115852A (en) 1999-09-22
YU49314B (sh) 2005-06-10
AU4110196A (en) 1996-07-03
DK0719788T3 (da) 1999-11-01
BR9509979A (pt) 1998-06-09
EP0719788A2 (de) 1996-07-03
ZA959320B (en) 1997-05-05
RO117327B1 (ro) 2002-01-30
CZ290941B6 (cs) 2002-11-13
PL181732B1 (en) 2001-09-28
AU689674B2 (en) 1998-04-02
NO972679L (no) 1997-06-11
KR100424991B1 (ko) 2004-05-20
HUT77929A (hu) 1998-11-30
ATE179986T1 (de) 1999-05-15
BG62738B1 (bg) 2000-06-30
CO4520286A1 (es) 1997-10-15
EP0719788B1 (de) 1999-05-12
EP0719788A3 (de) 1996-09-25
MY112488A (en) 2001-06-30
WO1996018637A1 (en) 1996-06-20
HU219021B (hu) 2001-01-29
JPH10510806A (ja) 1998-10-20
US5808048A (en) 1998-09-15
TW379226B (en) 2000-01-11
MX9704322A (es) 1997-09-30
ES2130542T3 (es) 1999-07-01
CZ179897A3 (en) 1997-09-17
CN1047177C (zh) 1999-12-08
PE49296A1 (es) 1996-11-21
IL115852A0 (en) 1996-01-31
AR001041A1 (es) 1997-09-24
SI0719788T1 (en) 1999-10-31
PL321046A1 (en) 1997-11-24

Similar Documents

Publication Publication Date Title
DE69509624T2 (de) Verfahren zur Herstellung von 1-(2'-Deoxy-2',2'-difluoro-D-ribofuranosyl)-4-amino-pyrimidin-2-on-hydrochlorid
DE69522399D1 (de) Verfahren zur Herstellung von 1,2-Benzisothiazol-3-onen
DE59608829D1 (de) Verfahren zur Herstellung von 1,3-Dimethyl-5-fluor-pyrazol-4-carboxaniliden
DE59503847D1 (de) Verfahren zur Herstellung von 3,5-Dimethylpyrazol-blockierten Polyisocyanaten
DE59602230D1 (de) Verfahren zur Herstellung von 2,2-Difluorbenzo[1.3]dioxolcarbaldehyden
DE69828191D1 (de) Verfahren zur herstellung von 2,6-dialkylnaphthalin
DE69511788T2 (de) Verfahren zur Herstellung von 1,1,1,3,3-Pentafluorpropan
DE59510180D1 (de) Verfahren zur Herstellung von 4-Amino-2,2,6,6-tetramethyl-piperidin
DE59408701D1 (de) Verfahren zur Herstellung von 2,3,4,5-Tetrafluor-benzotrifluorid
DE69603530D1 (de) Verfahren zur Herstellung von 1,1-Difluorethan
DE59501060D1 (de) Verfahren zur Herstellung von 2,5-Dihydrofuran
DE69503100D1 (de) Verfahren zur Herstellung von 3,4-Carandiol
DE69508683T2 (de) Verfahren zur Herstellung von 2,6-Di-tert-alkylcyclohexanol
DE59401800D1 (de) Verfahren zur Herstellung von 1,1'-Binaphthylen
DE59500712D1 (de) Verfahren zur Herstellung von 4,6-Diaminoresorcin
DE69424475T2 (de) Verfahren zur Herstellung von 1-(2'-deoxy-beta-D-erythropentofuranosyl)-5-trifluormethyluracil Derivaten
DE69710294D1 (de) Verfahren zur Herstellung von 3,5,5-Trimethyl-Cyclohexa-3-en-1-on
DE59509651D1 (de) Verfahren zur Herstellung von 2,5-Dihydrofuran
DE69502242T2 (de) Verfahren zur Herstellung von 1,3-dialkyl-2-imidazolidinon
DE59500192D1 (de) Verfahren zur Herstellung von 1-Amino-1-methyl-3(4)-cyano-cyclohexan
DE69500601D1 (de) Verfahren zur Herstellung von Dianthrachinon-N,N'-dihydroazin
DE69802312T2 (de) Verfahren zur Herstellung von 3,3',5,5'-Tetra-b-Butylbiphenol
DE59603698D1 (de) Verfahren zur Herstellung von 1,2,4-Triazoliumsalzen und 1,2,4-Triazolinen
DE59610341D1 (de) Verfahren zur Herstellung von 2,4,6-Trichlorpyrimidin
DE59504600D1 (de) Verfahren zur Herstellung von 2-Halogen-4,5-difluor-benzofluoriden

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN